Coronary artery disease and familial hypercholesterolaemia patients' eligibility for pcsk-9 inhibitors: who is to benefit from lower ldl thresholds?

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Lipids ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by